659 related articles for article (PubMed ID: 10877827)
1. Natriuretic peptides: a new lipolytic pathway in human adipocytes.
Sengenès C; Berlan M; De Glisezinski I; Lafontan M; Galitzky J
FASEB J; 2000 Jul; 14(10):1345-51. PubMed ID: 10877827
[TBL] [Abstract][Full Text] [Related]
2. Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells.
Moro C; Galitzky J; Sengenes C; Crampes F; Lafontan M; Berlan M
J Pharmacol Exp Ther; 2004 Mar; 308(3):984-92. PubMed ID: 14634036
[TBL] [Abstract][Full Text] [Related]
3. Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women.
Sengenes C; Stich V; Berlan M; Hejnova J; Lafontan M; Pariskova Z; Galitzky J
Int J Obes Relat Metab Disord; 2002 Jan; 26(1):24-32. PubMed ID: 11791143
[TBL] [Abstract][Full Text] [Related]
4. [Natriuretic peptides: a new lipolytic pathway in human fat cells].
Sengenes C; Moro C; Galitzky J; Berlan M; Lafontan M
Med Sci (Paris); 2005 Dec; 21 Spec No():29-33. PubMed ID: 16598902
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans.
Moro C; Crampes F; Sengenes C; De Glisezinski I; Galitzky J; Thalamas C; Lafontan M; Berlan M
FASEB J; 2004 May; 18(7):908-10. PubMed ID: 15033935
[TBL] [Abstract][Full Text] [Related]
6. [Natriuretic peptides: a new lipolytic pathway in human fat cells].
Sengenes C; Moro C; Galitzky J; Berlan M; Lafontan M
Med Sci (Paris); 2005 Jan; 21(1):61-5. PubMed ID: 15639022
[TBL] [Abstract][Full Text] [Related]
7. Stimulatory and Inhibitory regulation of lipolysis by the NPR-A/cGMP/PKG and NPR-C/G(i) pathways in rat cultured adipocytes.
Nishikimi T; Iemura-Inaba C; Akimoto K; Ishikawa K; Koshikawa S; Matsuoka H
Regul Pept; 2009 Feb; 153(1-3):56-63. PubMed ID: 19027799
[TBL] [Abstract][Full Text] [Related]
8. Altered role of C-type natriuretic peptide-activated pGC-cGMP-PDE3-cAMP signaling in hyperthyroid beating rabbit atria.
Wen JF; Quan HX; Zhou GH; Cho KW
Regul Pept; 2007 Aug; 142(3):123-30. PubMed ID: 17531330
[TBL] [Abstract][Full Text] [Related]
9. Differential function of the alpha2A-adrenoceptor and Phosphodiesterase-3B in human adipocytes of different origin.
Dicker A; Kaaman M; van Harmelen V; Aström G; Blanc KL; Rydén M
Int J Obes (Lond); 2005 Dec; 29(12):1413-21. PubMed ID: 16077714
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes.
Xue B; Greenberg AG; Kraemer FB; Zemel MB
FASEB J; 2001 Nov; 15(13):2527-9. PubMed ID: 11641262
[TBL] [Abstract][Full Text] [Related]
11. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
[TBL] [Abstract][Full Text] [Related]
12. The atrial natriuretic peptide- and catecholamine-induced lipolysis and expression of related genes in adipose tissue in hypothyroid and hyperthyroid patients.
Polak J; Moro C; Klimcakova E; Kovacikova M; Bajzova M; Vitkova M; Kovacova Z; Sotornik R; Berlan M; Viguerie N; Langin D; Stich V
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E246-51. PubMed ID: 17389707
[TBL] [Abstract][Full Text] [Related]
13. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.
Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis.
Moro C; Klimcakova E; Lafontan M; Berlan M; Galitzky J
Br J Pharmacol; 2007 Dec; 152(7):1102-10. PubMed ID: 17906676
[TBL] [Abstract][Full Text] [Related]
15. Differences in the amount of lipolysis induced by atrial natriuretic peptide in small and large adipocytes.
Yu J; Yu HC; Kim KA; Kwon KB; Park JW; Kim SZ; Kim SH; Park BH
J Pept Sci; 2008 Aug; 14(8):972-7. PubMed ID: 18383440
[TBL] [Abstract][Full Text] [Related]
16. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide regulates lipid mobilization and oxygen consumption in human adipocytes by activating AMPK.
Souza SC; Chau MD; Yang Q; Gauthier MS; Clairmont KB; Wu Z; Gromada J; Dole WP
Biochem Biophys Res Commun; 2011 Jul; 410(3):398-403. PubMed ID: 21672517
[TBL] [Abstract][Full Text] [Related]
18. Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity.
Sengenès C; Zakaroff-Girard A; Moulin A; Berlan M; Bouloumié A; Lafontan M; Galitzky J
Am J Physiol Regul Integr Comp Physiol; 2002 Jul; 283(1):R257-65. PubMed ID: 12069952
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
Mouawad R; Li Y; Anand-Srivastava MB
Mol Pharmacol; 2004 Apr; 65(4):917-24. PubMed ID: 15044621
[TBL] [Abstract][Full Text] [Related]
20. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
Elks ML; Manganiello VC
Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
